BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

BHVN upcoming catalysts

Biohaven Therapeutics Ltd.: 2 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (1 Phase 3), 1 upcoming FDA decision event(s), and in the last 12 months 5 readout(s) and 0 FDA event(s). Subscribe to BHVN (.ics).

Drugs: BHV-7000

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
2027-01-01 (quarter)PDUFA date (company-disclosed)pendingBiohaven Ltd. BHVNPDUFA first quarter of 2027 - Biohaven Ltd.

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12 est.P2/P3Biohaven Therapeutics Ltd. BHVNNCT06132893 A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyFocal Epilepsyactive not recruiting390
2026-12 est.P2Biohaven Therapeutics Ltd. BHVNNCT06443463 Long-term Safety and Tolerability of BHV-7000Focal Epilepsyenrolling by invitation660

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
No FDA decision events in this window.

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-10 est.P2/P3Biohaven Therapeutics Ltd. BHVNNCT06309966 Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyFocal Epilepsyactive not recruiting390
2026-09 est.P2Biohaven Therapeutics Ltd. BHVNNCT07281495 Taldefgrobep Alfa in Adults With Overweight and ObesityObesity; Overweightactive not recruiting150
2026-03-18P2Biohaven Therapeutics Ltd. BHVNNCT06423781 Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)Major Depressive Disordercompleted233
2026-03-12P2/P3Biohaven Therapeutics Ltd. BHVNNCT06425159 A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic SeizuresGeneralized Epilepsyterminated27
2026-02-13P3Biohaven Pharmaceuticals, Inc. BHVNNCT04708834 Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive DisorderObsessive Compulsive Disorderterminated772

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.